Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-79 |
Sentence |
denotes |
Short-course postpartum (6-h) magnesium sulfate therapy in severe preeclampsia. |
TextSentencer_T2 |
80-90 |
Sentence |
denotes |
OBJECTIVE: |
TextSentencer_T3 |
91-247 |
Sentence |
denotes |
To assess the efficacy of short-course postpartum (6-h) magnesium sulfate therapy versus 24-h conventional magnesium sulfate therapy in severe preeclampsia. |
TextSentencer_T4 |
248-256 |
Sentence |
denotes |
METHODS: |
TextSentencer_T5 |
257-351 |
Sentence |
denotes |
Cases of severe preeclampsia were randomly allocated to group A (n = 76) and group B (n = 43). |
TextSentencer_T6 |
352-488 |
Sentence |
denotes |
Group A and group B received magnesium sulfate loading dose (4 g) followed by infusion for 6 and 24 h postpartum (1 gm/h), respectively. |
TextSentencer_T7 |
489-625 |
Sentence |
denotes |
Cases in both the groups were monitored closely after the initiation of therapy. t test and Chi-square test were used for data analysis. |
TextSentencer_T8 |
626-634 |
Sentence |
denotes |
RESULTS: |
TextSentencer_T9 |
635-702 |
Sentence |
denotes |
No occurrence of convulsions was noted in both group A and group B. |
TextSentencer_T10 |
703-817 |
Sentence |
denotes |
The mean amount of magnesium sulfate used in the study group was 15.1 ± 5.4 g as against 42.3 ± 7.3 g in controls. |
TextSentencer_T11 |
818-1026 |
Sentence |
denotes |
The duration of Foley catheterization and monitoring was significantly less in group A (mean 11.3 ± 5.1 and 11.1 ± 4.9 h, respectively) as compared to group B (mean 38.3 ± 7.3 and 38.4 ± 7.2 h, respectively). |
TextSentencer_T12 |
1027-1254 |
Sentence |
denotes |
The mean duration of hospital stay was 2.7 ± 0.7 days in cases delivered vaginally and 7.5 ± 1.6 days in those who underwent cesarean section in group A, while it was 4.04 ± 1.47 and 11.11 ± 3.14 days, respectively, in group B. |
TextSentencer_T13 |
1255-1266 |
Sentence |
denotes |
CONCLUSION: |
TextSentencer_T14 |
1267-1452 |
Sentence |
denotes |
Short-course, i.e., 6-h, postpartum magnesium sulfate therapy is as effective as conventional 24-h postpartum magnesium sulfate therapy in preventing convulsions in severe preeclampsia. |
T1 |
0-79 |
Sentence |
denotes |
Short-course postpartum (6-h) magnesium sulfate therapy in severe preeclampsia. |
T2 |
80-90 |
Sentence |
denotes |
OBJECTIVE: |
T3 |
91-247 |
Sentence |
denotes |
To assess the efficacy of short-course postpartum (6-h) magnesium sulfate therapy versus 24-h conventional magnesium sulfate therapy in severe preeclampsia. |
T4 |
248-256 |
Sentence |
denotes |
METHODS: |
T5 |
257-351 |
Sentence |
denotes |
Cases of severe preeclampsia were randomly allocated to group A (n = 76) and group B (n = 43). |
T6 |
352-488 |
Sentence |
denotes |
Group A and group B received magnesium sulfate loading dose (4 g) followed by infusion for 6 and 24 h postpartum (1 gm/h), respectively. |
T7 |
489-625 |
Sentence |
denotes |
Cases in both the groups were monitored closely after the initiation of therapy. t test and Chi-square test were used for data analysis. |
T8 |
626-634 |
Sentence |
denotes |
RESULTS: |
T9 |
635-702 |
Sentence |
denotes |
No occurrence of convulsions was noted in both group A and group B. |
T10 |
703-817 |
Sentence |
denotes |
The mean amount of magnesium sulfate used in the study group was 15.1 ± 5.4 g as against 42.3 ± 7.3 g in controls. |
T11 |
818-1026 |
Sentence |
denotes |
The duration of Foley catheterization and monitoring was significantly less in group A (mean 11.3 ± 5.1 and 11.1 ± 4.9 h, respectively) as compared to group B (mean 38.3 ± 7.3 and 38.4 ± 7.2 h, respectively). |
T12 |
1027-1254 |
Sentence |
denotes |
The mean duration of hospital stay was 2.7 ± 0.7 days in cases delivered vaginally and 7.5 ± 1.6 days in those who underwent cesarean section in group A, while it was 4.04 ± 1.47 and 11.11 ± 3.14 days, respectively, in group B. |
T13 |
1255-1266 |
Sentence |
denotes |
CONCLUSION: |
T14 |
1267-1452 |
Sentence |
denotes |
Short-course, i.e., 6-h, postpartum magnesium sulfate therapy is as effective as conventional 24-h postpartum magnesium sulfate therapy in preventing convulsions in severe preeclampsia. |